Health Economics Review

Papers
(The H4-Index of Health Economics Review is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Contracting with sequential care providers93
Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship78
The healthcare costs of increased body mass index–evidence from The Trøndelag Health Study74
The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy51
End-of-life expenditure on health care for the older population: a scoping review37
A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England30
Valuation of informal care for the old-aged with disabilities in China—a discrete choice experiment approach30
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review28
Does long-term care insurance promote assistive device utilization? Evidence from pilot regions in China27
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea27
Building an integrated healthcare system of China: an assessment of coupling coordination between disease prevention, medical services, and healthcare financing from 2012 to 202126
Policies and cost analyses of voluntary assisted dying (VAD) laws – a mapping review & analysis25
Utilization of maternal health facilities and rural women’s well-being: towards the attainment of sustainable development goals25
Understanding women’s preferences for long-acting reversible contraceptives in Gondar, Ethiopia: a discrete choice experiment23
Impact of diabetes diagnosis on dental care utilization: evidence from Finland23
Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan22
Economic evidence of alternative formulations and routes of administration for identical active pharmaceutical ingredient: a systematic review22
Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)22
Behavioral responses of healthcare providers to prospective payment systems: a systematic review using the WHO framework (2000–2024)22
The economic impact of anastomotic leak after colorectal cancer surgery20
0.097057819366455